Ashland Global Hlds

Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. It operates through the following segments: Life Sciences, Personal Care, Special Additives, and Intermediates. The company was founded in 1924 and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Ashland Global Hlds reports solid Q1 performance amidst regional challenges

Ashland Global Hlds' Q1 earnings call highlighted a mix of strong performance, challenges in certain regions, and opportunities for growth through strategic initiatives. The company's focus on enhancing shareholder value, addressing market uncertainties, and driving innovation positions it for future success.

Ashland Global Hlds faces Q2 challenges, eyes pharma growth

Ashland Global Hlds faced challenges in Q2 2023 from global uncertainties and destocking, impacting margins and earnings, while showing strength in the pharma and Life Sciences segments.
The company's strategic focus on M&A in growth areas and ending destocking actions in key segments present opportunities for revenue growth and value creation.
Despite challenges, Ashland's performance reflects resilience and strategic decision-making, with a positive outlook for cash flow improvement and long-term growth.
Investors should monitor the company's progress in addressing challenges, leveraging strengths, and capitalizing on opportunities to drive sustainable financial performance.

Ashland Global Hlds faces destocking challenges but emphasizes resilience and growth

Ashland Global Hlds faced challenges from customer destocking, leading to a decline in sales and adjusted EBITDA, but demonstrated resilience and strength in managing mix improvements and margins.
The company remains focused on innovation, growth opportunities, and market confidence, with investments in core assets and new technologies continuing despite market challenges.
Opportunities lie in new product initiatives, global expansion, and capacity additions in key technologies, positioning Ashland Global Hlds for future growth and success.
Despite short-term challenges, Ashland Global Hlds maintains a strategic outlook, emphasizing long-term strategies, market confidence, and a commitment to driving growth through innovation.

Ashland Global Hlds faces challenges but targets growth opportunities

Ashland Global Hlds faced challenges in Q4 and anticipates uncertainties in 2024 but remains focused on long-term growth opportunities.
The company is optimizing its portfolio, targeting new growth drivers, and managing costs effectively to navigate current market conditions.
Despite near-term challenges, Ashland is resilient and committed to maximizing upside potential while minimizing downside risks.
Management's emphasis on proactive inventory control, cost management, and strategic priorities underscores their commitment to long-term success.

Ashland Global Hlds reports mixed Q1 results, focuses on long-term growth

Ashland Global Hlds reported mixed Q1 results with sales decline and EBITDA decrease, focusing on long-term growth strategies and shareholder value creation.
Challenges include lower demand in key units, compensation adjustments, market dynamics, and cost management considerations, while opportunities lie in M&A, innovation, and market expansion.
Stability in certain business segments and strategic initiatives to optimize operations provide a foundation for future growth and profitability amidst current challenges.
Overall, Ashland's performance reflects a balancing act between short-term setbacks and long-term strategic positioning for sustainable growth and market competitiveness.

Ashland Global Hlds beats Q2 expectations, eyes growth opportunities

Ashland Global Hlds demonstrated resilience in Q2 2024, exceeding EBITDA outlook and focusing on strategic growth.
Despite challenges in pricing and market dynamics, the company maintains a strong financial position and growth focus.
Opportunities lie in innovation, segment growth, and EBITDA normalization above 2021 levels.
The company's performance reflects a balance of challenges, strengths, and a proactive approach to future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.

WILMINGTON, DELAWARE, Jan.  09, 2020  (GLOBE NEWSWIRE) -- Ashland Global Holdings Inc. (NYSE: ASH) today announced the pricing of an offering by its indirect, wholly owned subsidiary Ashland Services B.V. of €500 million (approximately $560 million) aggregate principal amount of 2.000% senior notes due 2028 (the “Notes”).  

Ashland Global Holdings Inc. announces pricing of senior euro-denominated notes offering by Ashland Services B.V.

WILMINGTON, DELAWARE, Jan.  09, 2020  (GLOBE NEWSWIRE) -- In line with the recently communicated business unit structure, Ashland today announced Ashok Kalyana will be joining Ashland, to lead the Life Sciences business unit, effective Jan. 31, 2020. Kalyana will report directly to Guillermo Novo, chairman and chief executive officer.

Ashland announces new Life Sciences business leader

The notes will be guaranteed initially by Ashland (ASH) and its fully-owned subsidiary, Ashland LLC.

Ashland's (ASH) Subsidiary Announces Senior Notes Offering

Ashland (ASH) plans to implement core changes, resource management, leadership teams, processes and financial reporting during the second quarter of fiscal 2020.

Ashland (ASH) to Realign Business Operations Starting 2020

Covington, Kentucky, Dec.  18, 2019  (GLOBE NEWSWIRE) -- In line with the recently communicated business unit structure, Ashland today announced Min Chong will be joining Ashland, to lead the Specialty Additives business unit, effective Jan. 1, 2020, and Tim Pione will be leading the Performance Adhesives business unit.  Both Chong and Pione will report directly to Guillermo Novo, chairman and chief executive officer.

Ashland announces new Specialty Additives and Adhesives business leaders

Covington, Kentucky, Dec.  17, 2019  (GLOBE NEWSWIRE) -- Beginning in the second quarter of fiscal 2020, Ashland will change the manner in which it manages the business, moving from a functionally-led organization to a business-unit focused organization. This change recognizes that we have a diverse portfolio of businesses with different value propositions for the markets we serve. These changes will enable us to align our business models, resources and cost structure to the specific needs of each business unit and create greater ownership and accountability for both short- and long-term performance. We also plan to align incentive rewards with business-unit performance. 

Ashland announces business realignment

Ashland's (ASH) new defoamers have an overall improved cost efficiency.

Ashland Launches Two New Hydrophobic Polymers-Based Defoamers

Ashland (ASH) faced challenges from softer industrial end-market demand and weak results at Pharmachem and Personal Care businesses in Q4.

Ashland (ASH) Earnings & Sales Fall Short of Estimates in Q4

Ashland Global Holdings Inc. (ASH) CEO Bill Wulfsohn on Q4 2019 Results - Earnings Call Transcript

Ashland (ASH) delivered earnings and revenue surprises of -21.43% and -5.12%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Ashland (ASH) Q4 Earnings and Revenues Miss Estimates

Covington, Kentucky, Nov.  14, 2019  (GLOBE NEWSWIRE) -- The board of directors of Ashland Global Holdings Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.275 per share on the company's common stock. The dividend is payable December 15, 2019, to stockholders of record at the close of business on December 2, 2019. As of October 31, 2019, there were 60,183,754 shares of Ashland common stock outstanding.

Ashland board  declares quarterly dividend

Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ashland (ASH) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Guillermo Novo to Succeed William A. Wulfsohn as Chairman and Chief Executive Officer, Effective December 31, 2019 Guillermo Novo to Succeed William A. Wulfsohn as Chairman and Chief Executive Officer, Effective December 31, 2019

Ashland Announces CEO Transition

Covington, Kentucky, Sept.  03, 2019  (GLOBE NEWSWIRE) -- Ashland Global Holdings Inc. (NYSE: ASH) today announced it has completed the previously announced sale of its Composites business (excluding the Maleic business) and butanediol manufacturing facility in Marl, Germany to INEOS Enterprises in a transaction valued at $1.015 billion.

Ashland completes sale of Composites business and butanediol facility in Marl, Germany to INEOS Enterprises for $1.015 billion

Booking Hlds

Chevron

O'Reilly Automotive

Diamond Hill Capital (Trades, Portfolio) disclosed last week that its six biggest buys for the second quarter were: Booking Holdings Inc.

Diamond Hill Capital’s Top 4 Buys in 2nd Quarter

Ashland Global Holdings Inc. (ASH) CEO Bill Wulfsohn on Q3 2019 Results - Earnings Call Transcript

Ashland (ASH) delivered earnings and revenue surprises of 0.00% and 0.19%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Ashland (ASH) Q3 Earnings Meet Estimates

Ashland, Inc. (ASH) CEO Bill Wulfsohn on Q2 2019 Results - Earnings Call Transcript

Earnings Preview: Ashland (ASH) Q2 Earnings Expected to Decline

Per Ashland (ASH), the hike is mainly driven by persistent increase in cost of key raw materials, freight and tariffs.

Ashland to Hike Price of Composites Products in North America

Ashland's (ASH) move is in response to the persistent increase in cost of key raw materials.

News for Ashland Global Hlds Stock (ASH)